Marksans Pharma LimitedNSE: MARKSANS

Press Release Jul 02 2024

· Issued by Marksans Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-02-2024-13

Marksans Pharma Limited has informed the Exchange regarding a press release dated July 02, 2024, titled "Marksans Pharma Limited s wholly owned subsidiary Relonchem Limited receives Marketing Authorization for its products ".

View Attachment

6ix hasn’t read this filing yet.

Marksans Pharma Limited on 6ix

Earlier from Marksans Pharma

Later from Marksans Pharma

All Marksans Pharma news releases